Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells
Date:
2006-04-28
Recommended citation:
Coyle, Adrian T., Kinsella, B. Therese
: Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells. Biochemical Pharmacology, 71 (9) 2006-04-28, pp.1308-1323.
Abstract:
The human thromboxane (TX)A2 receptor (TP) gene encodes two TP isoforms, TPalpha and TP beta that are regulated by distinct promoters designated promoter (Prm) 1 and Prm3, respectively. Previous studies established that 15d-delta 12,14-prostaglandin J2 (15d-PGJ2) selectively inhibits Prm3 activity and TP beta expression through a peroxisome proliferator-activated receptor (PPAR)gamma mechanism without affecting Prm1 activity or TPalpha expression in human megakaryocytic erythroleukemia (HEL) 92.1.7 cells. Herein, we investigated the effect of synthetic thiazolidinedione (TZD) PPARgamma ligands rosiglitazone and troglitazone on TP gene expression in HEL cells. Like 15d-PGJ2, both TZDs suppressed Prm3 activity, TPbeta mRNA expression and TP-mediated calcium mobilization without affecting Prm1 or TPalpha mRNA expression. However, unlike 15d-PGJ2, both TZDs mediated their PPARgamma-dependent effects through trans-repression of an activator protein-1 (AP-1) element, a site previously found to be critical for basal Prm3 activity. These data provide further evidence for the role of PPARgamma in regulating the human TP gene; they highlight further differences in TPalpha and TPbeta expression/regulation and point to essential differences between natural and synthetic PPARgamma agonists in mediating those effects.
Date:
Effect of thiazolidinedione derivatives on thromboxane A2 receptor gene expression
Funding Details:
Health Research Board
Funding Details:
Wellcome Trust
Type of material:
Journal Article
Publisher:
Elsevier
Copyright (published version):
2006 Elsevier Inc.
Rights statement:
This is the author’s version of a work that was accepted for publication in Biochemical Pharmacology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Biochemical Pharmacology Volume 71, Issue 9, 28 April 2006, Pages 1308-1323 DOI 10.1016/j.bbalip.2006.07.012.
ISSN:
0006-2952
Medical Subject Headings:
Receptors, Thromboxane; Promoter Regions, Genetic; Peroxisome Proliferator-Activated Receptors; Thiazolidinediones; Prostaglandin D2--analogs & derivatives
Status of item:
Peer reviewed
Language:
en
Availability:
Full text available
Available:
2011-09-02T14:35:05Z
Show full item record
Files in this item
This item appears in the following Collection(s)
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.
If you are a publisher or author and have copyright concerns for any item, please email research.repository@ucd.ie and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.
RSS